İstanbul Florence Nightingale Hastanesi
Özel İlgi Alanları
-
2020
İstanbul Florence Nightingale Hastanesi
Hematoloji
2010
Şişli Florence Nightingale Hastanesi
Kemik İliği Nakli Merkezi / Kurucu
2007-2009
Ankara Üniversitesi Tıp Fakültesi
Komite Başkanlığı
2001
Ankara Üniversitesi Tıp Fakültesi
Hematoloji Yandal Eğitimi
1996
Ankara Üniversitesi Tıp Fakültesi
İç Hastalıkları Uzmanlık Eğitimi
1991
Hacettepe Üniversitesi Tıp Fakültesi
Tıp Eğitimi -
- Türk Hematoloji Derneği Aferez Altkomitesi Sekreterliği (29.11.2002-1.10.2004)
- Türk Hematoloji Derneği Web Sayfası Eş Koordinatörü (2003-2007)
- THD Genel Sekreteri (02.10.2005- )
- Türkiye İç Hastalıkları Uzmanları Derneği, TİHUD
- Türkiye Bilimler Akademisi (TÜBA) Kök Hücre Grubu (2006- )
- Febril Nötropeni Derneği
- Hemaferezis Derneği (Kurucu Üye)
- Sayman Üye (30.10.2004- 15.10.2006)
- European Blood and Marrow Transplantation Group (EBMT)
- LEWP sekreteri (1 Nisan 2006- )
- Joint Accreditation Committee ISHAGE Europe (JACIE)
- Inspector (Clinic/Collection Facility) (31.08.2004- )
- European Hematology Association (EHA)(Üye No. 3873)
- EHA Education Committee (2009- )
- American Society of Hematology (ASH, #1001725)
- American Society of Bone Marrow Transplantation ( ASBMT, #4565
-
Uluslararası Hakemli Dergilerde Yayımlanan Makaleler
- 1. Koç H, Arslan Ö, Gürman G, Akan H, Özcan M, İlhan O, Aydoğdu İ, Arat M, Beksaç M, Konuk N, Uysal A. The use of high dose chemotherapy plus granulocyte colony stimulating factor for the salvage of refractory ort resistant relapse malignant lymphoma patients without stem cell support. Acta Haematol 1997; 98: 136-139
- 2. Dilek İ, Demirer T, Üstün C, Arat M, Koç H, Beksaç M, Erdi H, Anadolu R, Özcan M, İhan O, Akan H. Acquired icthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantion in a patient wİth chronic myelogenous leukemia. Bone Marrow Transplant 1998; 21: 1159-1161
- 3. Beksaç M, Arslan Ö, Koç H, Akan H, İlhan O, Arat M, Özcan M, Gürman G, Konuk N., Uysal A. Randomized unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukemia. Medical Oncology 1998; 15: 183-190
- 4. Beksaç M, Arat M, İdilman R. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced indolent non-Hodgkin's lymphoma. Cancer 1998; 85: 242 (letter)
- 5. Arslan Ö, Üstün C, Arat M, Çelebi H, Akan H, Beksaç M, Ilhan O, Gürman G, Özcan M, Konuk N, Uysal A, Koç H. Allogeneic peripheral blood stem cell transplantation in acute nonlymphoblastic leukemia. Hematol Oncol 1998; 16: 115-162
- 6. Üstün C, Arslan Ö, Beksaç M, Koç H, Gürman G, Özçelik T, Yılmaz B, İlhan O, Akan H, Özcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek İ, Çelebi H, Çoşkun HŞ. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center, a focus on the incidence of GVHD and relapse. Biol Blood Marrow Transplant 1999;5:28-35
- 7. İlhan O, Arslan Ö, Arat M, Beksaç M, Akan H, Koç H, Dilek İ, Özcan M, Gürman G, Konuk N, Uysal A. The impact of CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation. Trans Sci 1999;20:69-71
- 8. Üstün C, Çelebi H, Arat M, Özcan M, Dilek İ, Gürman G, Demirer T, İlhan O, Keskin R, Koç H. Treatment of aregeneratoric anemia following an ABO-Incompatible allogeneic peripheral blood stem cell transplantation. Ther Apher 1999;3:275-77 9
- 9. Demirer T, Çelebi H, Arat M, Üstün C, Demirer S, Dilek İ, Özcan M, İlhan O, Akan H, Gürman G, Koç H. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy following an autologous blood stem cell transplantation: a case report. Bone Marrow Transplant 1999;24:335-338
- 10. Üstün C, Özcan M, Gürman G, Çakır M, Erekul S, Akyol G, Arat M, Çelebi H, İdilman R, İhan O, Demirer T, Beksaç M, Koç H. Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft versus host disease. Pathol Oncol Res 1999;5:229-232
- 11. Demirer T, llhan O, Mandel N.M., Arat M, Günel N, Çelebi H, Üstün C, Akan H, Demirer S, Aydıntuğ S, Uysal A and Koç H. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies . Bone Marrow Transplant 2000;25:697-703
- 12. Arslan Ö, Coşkun H.Ş, Arat M, Çelebi H, Özcan M, Gürman G, Üstün C, Demirer T, Akan H, İlhan O, Konuk N, Beksaç M, Uysal A, Koç H. Allogeneic peripheral blood stem cell transplantation for standard risk leukemias: Four years experience of Ibni Sina Hospital. Bone Marrow Transplant 2000;25:1229-1232
- 13. Arslan Ö, Akan H, Arat M, Dalva K, Özcan M, Gürman G, İlhan O, Konuk N, Beksaç M, Uysal A, Koç H. Soluble adhesion molecules (sICAM-l, sL-Selectin, sE-Selectin, sCD44) in healthy allogeneic peripheral stem cell donors primed with recombinant granulocyte colony stimulating factor. Cytother 2000; 2: 259-265
- 14. Ilhan O, Üskent N, Arslan Ö, Arat M, Özkalemkaş F, Öztürk G, Kalayoğlu S.B, Özet A, Tombuloğlu M, Arpacı F, Ovalı E, Anak S. On behalf of Turkish Apheresis Group. National survey of hemapheresis practice in Turkey (1998) Trans Sci 2000; 22: 195-201
- 15. Akan H, Güven N, Aydoğdu I, Arat M, Beksaç M, Dalva K. Thrombopoietic cytokines in patinents with iron deficiency anemia with or without thrombocytosis. Acta Haematol 2000; 103: 152-156
- 16. Beksaç M, Arat M, Akan H, Koç H, İlhan O, Özcan M. Circulating CD44 and ICAM-1 levels in low grade non-Hodgkin's lymphoma and B-CLL patients during interferon alpha- 2a treatment. Cancer 2000; 89: 1474-1481
Video